Receptor mechanisms mediating cyanide generation in PC12 cells and rat brain

Neuroscience Research

Volumn 49, Issue 1, 2004, Pages 13-18

  Gunasekar, P G ^a,b   Prabhakaran, K ^a   Li, L ^a   Zhang, L ^a   Isom, G E ^a   Borowitz, J L ^a  

^a PURDUE UNIVERSITY   (United States)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Atropine; Carbachol; Chelerythrine; Hydromorphone; Muscarinic receptors; Naloxone; Opiate receptors; Protein kinase C

Indexed keywords

ATROPINE; CARBACHOL; CHELERYTHRINE; CYANIDE; DIHYDROMORPHINE; MUSCARINIC AGENT; NALOXONE; OPIATE AGONIST; OPIATE ANTAGONIST; OXOTREMORINE; PERTUSSIS TOXIN;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; FEMALE; MALE; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ATROPINE; BRAIN; CARBACHOL; CELLS, CULTURED; CHOLINERGIC AGONISTS; CYANIDES; DRUG INTERACTIONS; EMBRYO; HYDROMORPHONE; MORPHINE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; OXOTREMORINE; PC12 CELLS; PERTUSSIS TOXIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE;

EID: 16544371589     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2004.01.006     Document Type: Article

References (26)

1. Badiani A., Castellano C., Oliverio A. Effects of acute and chronic stress and of genotype on oxotremorine-induced locomotor depression in mice. Behav. Neural. Biol. 55:1991;123-130.
2. Borowitz J.L., Gunasekar P.G., Isom G.E. Hydrogen cyanide generation by μ opiate receptor activation: possible neuromodulatory role of endogenous cyanide. Brain Res. 768:1997;294-300.
3. Brown, J.B., Taylor, P., 2001. Muscarinic receptor agonists and antagonists. In: Hardman, J., Limbird, L. (Eds.), The Pharmacological Basis of Therapeutics, 10th ed., McGraw-Hill, New York, p. 164.
4. Ewing J., Maines M. Histochemical localization of heme oxygenase-2 protein and mRNA expression in rat brain. Brain Res. Protocols. 1:1997;165-174.
5. 1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. J. Pharmacol. Exp. Ther. 257:1991;392-403.
6. Ganjeloo A., Isom G., Way J. Fluorimetric determination of cyanide in biological fluids with p-benzoquinone. Toxicol. Appl. Pharmacol. 55:1980;103-107.
7. Gunasekar P.G., Borowitz J.L., Isom G.E. Endogenous generation of cyanide in neuronal tissue: involvement of a peroxidase system. J. Neurosci. Res. 61:2000;570-575.
8. Hammer R., Ricalde A., Seatriz J. Effects of opiates on brain development. Neurotoxicology. 10:1989;475-484.
9. Johnson J., Meisenheimer T., Isom G. Cyanide-induced neurotoxicity: role of neuronal calcium. Toxicol. Appl. Pharmacol. 84:1986;464-469.
10. Kanthasamy A.G., Borowitz J.L., Pavlakovic G., Isom G.E. Dopaminergic neurotoxicology of cyanide: neurochemical, histological, and behavioral characterization. Toxicol. Appl. Pharmacol. 126:1994;156-163.
11. Kimura H. Hydrogen sulfide as a neuromodulator. Mol. Neurobiol. 26:2002;13-19.
12. Lambert J., Ramasamy J., Paukstelis J. Stable reagents for the colorimetric determination of cyanide by modified Koenig reactions. Anal. Chem. 47:1975;916-918.
13. Michel A., Stefanich E., Whiting R. PC12 pheochromocytoma cells contain an atypical muscarinic receptor binding site. Br. J. Pharmacol. 97:1989;914-920.
14. Mills E.M., Gunasekar P.G., Li L., Borowitz J., Isom G. Differential susceptibility of brain areas to cyanide involves different modes of cell death. Toxicol. Appl. Pharmacol. 156:1999;6-16.
15. Nakatsubo N., Kojima H., Kikuchi K., Nagoshi H., Hirata Y., Maeda D., Imai Y., Irimura T., Nagano T. Direct evidence of nitric oxide production using new fluorescence indicators: diaminofluoresceins. FEBS Lett. 427:1998;263-266.
16. Nestler, E., Greengard, P., 1993. Protein phosphorylation and the regulation of neuronal function. In: Siegal, G., Agaroff, W., Albers, R., Molinoff, P. (Eds.), Basic Neurochemistry, fifth ed., Raven Press, New York, p. 461.
17. Nishiki T., Shoji-Kasai Y., Sekiguchi M., Iwasaki S., Kumakura K., Takahashi M. Comparison of exocytotic mechanisms between acetylcholine- and catecholamine-containing vesicles in rat pheochromocytoma cells. Biochem. Biophys. Res. Commun. 239:1997;57-62.
18. Schliebs, R., Rossner, S., 1995. Distribution of muscarinic acetylcholine receptors in the CNS. In: Stone, T. (Ed.), CNS Neurotransmitters and Neuromodulators: Acetylcholine. CRC Press, London, pp. 67-83.
19. Shafer T., Atchison W. Transmitter, ion channel and receptor properties of pheochromocytoma (PC12 cells): a model for neurotoxicological studies. Neurotoxicology. 12:1991;473-492.
20. Timofeeva O.A., Gordon C.J. Changes in EEG power spectra and behavioral states in rats exposed to the acetylcholinesterase inhibitor chlorpyrifos and muscarinic agonist oxotremorine. Brain Res. 893:2001;165-177.
21. Venihaki M., Gravanis A., Margioris A. Opioids inhibit dopamine secretion from PC12 rat pheochromocytoma cells in a naloxone-reversible manner. Life Sci. 58:1996;75-82.
22. Wada K., Kamisaki Y., Ohkura T., Kanda G., Nakamoto K., Kishimoto Y., Ashida K., Itoh T. Direct measurement of nitric oxide release in gastric mucosa during ischemia-reperfusion in rats. Am. J. Physiol. 274:1998;G465-G471.
23. Wood, J., Garthwaite, J., 1994. Models of the diffusional spread of nitric oxide: implications for nitric oxide signaling and its pharmacological properties. Neuropharmacology 33, 1235-1244.
24. Zagon I., McLaughlin P. Increased brain size and cellular content in infant rats treated with an opiate antagonist. Science. 221:1983;1179-1180.
25. Zagon I., McLaughlin P. Endogenous opioid systems regulate cell proliferation in the developing rat brain. Brain Res. 412:1987;68-72.
26. Zhang J., Snyder S.H. Nitric oxide in the nervous system. Ann. Rev. Pharmacol. Toxicol. 35:1995;213-233.